Q&A with Francis Collins, Director of NIH Director Collins sees NIH as a catalyst for translating biomedical discoveries into effective therapies, but the skeptics fear it’s harder than it looks.

FEATURES

• Brand of the Year
This month, Pharm Exec honors its Brand of the Year. Although the winner remains under wraps for now, needless to say the honored drug will be praised for is innovation, growth, effectiveness, and market success.

• China Chartways
John Zifferblatt dissects China’s procurement issues and what is in store for the next two years. Are branded generics coming to an end? How will multinational pharmas respond? What are the threats and opportunities to China’s drug stores? Zifferblatt offers his firsthand knowledge.

COLUMNS

• Product Seizures:
How a quality-based approach to real-time product intelligence can reduce corporate risk and help to ensure delivery of safe, genuine products to patients

• Mobile Marketing:
How physicians are using smartphones to cut costs while also reaching patients more effectively